首页 > 最新文献

North American Spine Society Journal最新文献

英文 中文
A room with a view: Recovery bed environment following pediatric spinal fusion 视野开阔的房间:小儿脊柱融合术后的康复床环境
IF 2.5 Q3 Medicine Pub Date : 2026-01-09 DOI: 10.1016/j.xnsj.2026.100848
Alexa P. Bosco BA , Margaret L. Sullivan BS , Daniel Gabriel BA, MBA , Shanika De Silva PhD , Daniel Hedequist MD , Michael T. Hresko MD , Craig Munro Birch MD , Grant D. Hogue MD

Background Context

Patients in a double-occupancy room during recovery will have different experiences based on bed location. For instance, patients near a window will have access to natural light while a patient near the door may experience higher noise levels. This study aims to assess the impact of inpatient bed placement on postoperative recovery for adolescent idiopathic scoliosis (AIS) patients undergoing posterior spinal fusion (PSF).

Methods

This retrospective cohort study included 448 AIS patients who underwent PSF from 2011 to 2017 at a single center. Demographics and baseline radiographic measurements were summarized using appropriate statistics. Intraoperative and postoperative outcomes, NRS pain scores and total daily opioid administration were compared across bed types using t-tests, Wilcoxon rank sum tests, chi-squared tests, or Fisher’s exact tests, as appropriate. GEE models were constructed to examine the influence of bed type and days since surgery on outcomes such as postoperative complication, PACU pain levels, length of stay, daily numerical ranking scale (NRS) pain scores and total daily opioid administration.

Results

325 (73%) patients in the cohort were assigned to a bed by the window and 123 (27%) were assigned to a bed by the door. The mean age was 15±2 years and 85% of patients were female. Length of hospital stay, complication rates, 2-year outcomes, inpatient pain scores, and daily opioid usage did not significantly differ between bed types (all p>.05). Adjusted GEE models revealed no significant associations between bed type and pain scores (p=.9) or between bed type and total opioid dosage (p=.95).

Conclusions

Proximity to a window while recovering from PSF surgery for AIS does not impact inpatient outcomes. When bed space is scarce, usage of all available beds can serve as a relief valve to continue elective practices without compromising postoperative outcomes.
背景背景在双人病房中,病人在康复期间会有不同的体验,这取决于床位的位置。例如,靠近窗户的病人可以获得自然光,而靠近门的病人可能会经历更高的噪音水平。本研究旨在评估住院床位对青少年特发性脊柱侧凸(AIS)患者后路脊柱融合术(PSF)术后恢复的影响。方法本回顾性队列研究纳入了2011年至2017年在单中心接受PSF的448例AIS患者。人口统计学和基线放射测量用适当的统计总结。采用t检验、Wilcoxon秩和检验、卡方检验或Fisher精确检验比较不同床型的术中和术后结局、NRS疼痛评分和每日阿片类药物总给药量。构建GEE模型,研究床型和手术后天数对术后并发症、PACU疼痛水平、住院时间、每日数值排序量表(NRS)疼痛评分和每日阿片类药物总剂量等结果的影响。结果队列中325例(73%)患者被分配到靠窗的床位,123例(27%)患者被分配到靠门的床位。平均年龄15±2岁,85%为女性。住院时间、并发症发生率、2年结局、住院疼痛评分和每日阿片类药物使用在床位类型之间无显著差异(均为p>; 0.05)。调整后的GEE模型显示,床型与疼痛评分之间无显著相关性(p= 0.9),床型与阿片类药物总剂量之间无显著相关性(p= 0.95)。结论:AIS患者在PSF手术后恢复时靠近窗口不影响住院结果。当床位不足时,使用所有可用的床位可以作为一个安全阀,在不影响术后结果的情况下继续选择性手术。
{"title":"A room with a view: Recovery bed environment following pediatric spinal fusion","authors":"Alexa P. Bosco BA ,&nbsp;Margaret L. Sullivan BS ,&nbsp;Daniel Gabriel BA, MBA ,&nbsp;Shanika De Silva PhD ,&nbsp;Daniel Hedequist MD ,&nbsp;Michael T. Hresko MD ,&nbsp;Craig Munro Birch MD ,&nbsp;Grant D. Hogue MD","doi":"10.1016/j.xnsj.2026.100848","DOIUrl":"10.1016/j.xnsj.2026.100848","url":null,"abstract":"<div><h3>Background Context</h3><div>Patients in a double-occupancy room during recovery will have different experiences based on bed location. For instance, patients near a window will have access to natural light while a patient near the door may experience higher noise levels. This study aims to assess the impact of inpatient bed placement on postoperative recovery for adolescent idiopathic scoliosis (AIS) patients undergoing posterior spinal fusion (PSF).</div></div><div><h3>Methods</h3><div>This retrospective cohort study included 448 AIS patients who underwent PSF from 2011 to 2017 at a single center. Demographics and baseline radiographic measurements were summarized using appropriate statistics. Intraoperative and postoperative outcomes, NRS pain scores and total daily opioid administration were compared across bed types using t-tests, Wilcoxon rank sum tests, chi-squared tests, or Fisher’s exact tests, as appropriate. GEE models were constructed to examine the influence of bed type and days since surgery on outcomes such as postoperative complication, PACU pain levels, length of stay, daily numerical ranking scale (NRS) pain scores and total daily opioid administration.</div></div><div><h3>Results</h3><div>325 (73%) patients in the cohort were assigned to a bed by the window and 123 (27%) were assigned to a bed by the door. The mean age was 15±2 years and 85% of patients were female. Length of hospital stay, complication rates, 2-year outcomes, inpatient pain scores, and daily opioid usage did not significantly differ between bed types (all p&gt;.05). Adjusted GEE models revealed no significant associations between bed type and pain scores (p=.9) or between bed type and total opioid dosage (p=.95).</div></div><div><h3>Conclusions</h3><div>Proximity to a window while recovering from PSF surgery for AIS does not impact inpatient outcomes. When bed space is scarce, usage of all available beds can serve as a relief valve to continue elective practices without compromising postoperative outcomes.</div></div>","PeriodicalId":34622,"journal":{"name":"North American Spine Society Journal","volume":"25 ","pages":"Article 100848"},"PeriodicalIF":2.5,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Depression among lumbar spine surgery patients: Uncovering the untold story 腰椎手术患者的抑郁:揭露不为人知的故事
IF 2.5 Q3 Medicine Pub Date : 2026-01-03 DOI: 10.1016/j.xnsj.2025.100846
Aboubacar Wague BA , Jennifer M. O’Donnell MD , Nesa Milan MD , Alex Youn BA , Gurbinder Singh BS , Anna Filley MD , Avionna Baldwin MD , Zodina Beine MD , Aesha Ajose BS , Ashraf N. El Naga MD , David Gendelberg MD , Sigurd Berven MD

Background

Depression is highly prevalent among patients with lumbar degenerative disease and is associated with worse postoperative outcomes. However, a significant proportion of affected individuals remain undiagnosed. We aimed to evaluate the utility of PROMIS Depression scores in identifying patients with undiagnosed depression undergoing lumbar spine surgery and to characterize their clinical outcomes relative to patients with diagnosed and no depression.

Methods

This retrospective cohort study included patients undergoing 1- or 2-level lumbar decompression or fusion between March 2019 and November 2021. Patients were stratified into three cohorts: diagnosed depression (PDD), no depression (NDD), and at-risk for undiagnosed depression (ARUD), defined as PROMIS Depression ≥55 without an ICD-10 diagnosis. Patient-reported outcomes were assessed preoperatively and at 6, 12, and 24 months postoperatively. Between group comparisons and baseline-adjusted ANCOVA models were performed, including subgroup analyses by procedure type (fusion vs. decompression) and revision status.

Results

Of 286 ICD-10-negative patients, 24.1% (n=69) met criteria for ARUD. Patient-reported outcome scores across all domains in the ARUD cohort mirrored those of the PDD group and were significantly worse than those of the NDD cohort at all timepoints (p<.001). PROMIS Depression showed a strong correlation with Anxiety (ρ>0.77) and moderate correlations with other domains. No significant difference was observed in outcomes between treated and untreated PDD patients. Older age was associated with reduced likelihood of diagnosis, while substance abuse history, pain clinic enrollment, and retired status predicted higher risk of undiagnosed depression.

Conclusions

PROMIS Depression scores can identify patients with undiagnosed depression who experience similar impairments and postoperative outcomes as those with diagnosed depression. These findings support the routine use of PROMIS Depression as a screening tool to enhance preoperative psychiatric assessment in spine surgery patients.
背景:抑郁症在腰椎退行性疾病患者中非常普遍,并且与较差的术后预后相关。然而,很大一部分受影响的个体仍未得到诊断。我们的目的是评估PROMIS抑郁评分在识别接受腰椎手术的未确诊抑郁症患者中的效用,并相对于确诊和无抑郁症患者描述其临床结果。方法本回顾性队列研究包括2019年3月至2021年11月期间接受1或2节段腰椎减压或融合术的患者。患者被分为三个队列:诊断抑郁症(PDD),无抑郁症(NDD)和有未诊断抑郁症风险(ARUD),定义为PROMIS抑郁症≥55,无ICD-10诊断。术前、术后6个月、12个月和24个月评估患者报告的结果。进行组间比较和基线调整的ANCOVA模型,包括按手术类型(融合与减压)和翻修状态进行亚组分析。结果286例icd -10阴性患者中,符合ARUD标准的占24.1% (n=69)。在ARUD队列中,患者报告的所有领域的结果评分与PDD组的结果相一致,并且在所有时间点都明显低于NDD组(p<.001)。抑郁与焦虑有较强的相关关系(ρ>0.77),与其他领域有中等的相关关系。在治疗和未治疗的PDD患者之间没有观察到显著差异。年龄越大,诊断的可能性越低,而药物滥用史、疼痛门诊登记和退休状态预测未确诊抑郁症的风险更高。结论promis抑郁评分可以识别出未确诊的抑郁症患者,这些患者经历了与确诊抑郁症患者相似的损伤和术后结局。这些发现支持常规使用PROMIS抑郁作为筛查工具,以加强脊柱手术患者的术前精神评估。
{"title":"Depression among lumbar spine surgery patients: Uncovering the untold story","authors":"Aboubacar Wague BA ,&nbsp;Jennifer M. O’Donnell MD ,&nbsp;Nesa Milan MD ,&nbsp;Alex Youn BA ,&nbsp;Gurbinder Singh BS ,&nbsp;Anna Filley MD ,&nbsp;Avionna Baldwin MD ,&nbsp;Zodina Beine MD ,&nbsp;Aesha Ajose BS ,&nbsp;Ashraf N. El Naga MD ,&nbsp;David Gendelberg MD ,&nbsp;Sigurd Berven MD","doi":"10.1016/j.xnsj.2025.100846","DOIUrl":"10.1016/j.xnsj.2025.100846","url":null,"abstract":"<div><h3>Background</h3><div>Depression is highly prevalent among patients with lumbar degenerative disease and is associated with worse postoperative outcomes. However, a significant proportion of affected individuals remain undiagnosed. We aimed to evaluate the utility of PROMIS Depression scores in identifying patients with undiagnosed depression undergoing lumbar spine surgery and to characterize their clinical outcomes relative to patients with diagnosed and no depression.</div></div><div><h3>Methods</h3><div>This retrospective cohort study included patients undergoing 1- or 2-level lumbar decompression or fusion between March 2019 and November 2021. Patients were stratified into three cohorts: diagnosed depression (PDD), no depression (NDD), and at-risk for undiagnosed depression (ARUD), defined as PROMIS Depression ≥55 without an ICD-10 diagnosis. Patient-reported outcomes were assessed preoperatively and at 6, 12, and 24 months postoperatively. Between group comparisons and baseline-adjusted ANCOVA models were performed, including subgroup analyses by procedure type (fusion vs. decompression) and revision status.</div></div><div><h3>Results</h3><div>Of 286 ICD-10-negative patients, 24.1% (n=69) met criteria for ARUD. Patient-reported outcome scores across all domains in the ARUD cohort mirrored those of the PDD group and were significantly worse than those of the NDD cohort at all timepoints (p&lt;.001). PROMIS Depression showed a strong correlation with Anxiety (ρ&gt;0.77) and moderate correlations with other domains. No significant difference was observed in outcomes between treated and untreated PDD patients. Older age was associated with reduced likelihood of diagnosis, while substance abuse history, pain clinic enrollment, and retired status predicted higher risk of undiagnosed depression.</div></div><div><h3>Conclusions</h3><div>PROMIS Depression scores can identify patients with undiagnosed depression who experience similar impairments and postoperative outcomes as those with diagnosed depression. These findings support the routine use of PROMIS Depression as a screening tool to enhance preoperative psychiatric assessment in spine surgery patients.</div></div>","PeriodicalId":34622,"journal":{"name":"North American Spine Society Journal","volume":"25 ","pages":"Article 100846"},"PeriodicalIF":2.5,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Portal message utilization in orthopedic spine surgery: patterns, predictors, and financial implications 骨科脊柱外科中门户信息的利用:模式、预测因素和财务影响
IF 2.5 Q3 Medicine Pub Date : 2025-12-31 DOI: 10.1016/j.xnsj.2025.100845
Sydney Rucker BA , Michal C Williams BS , Robert J. Ferdon MS , Jason Silvestre MD , Charles Reitman MD , Robert Ravinsky MDCM, MPH, FRCSC

Background

Electronic patient portals (EPPs) facilitate communication between patients and providers, but their utilization and impact in orthopedic spine surgery are poorly defined. This study aims to quantify portal message volume and content, identified demographic predictors of high utilization, and estimated the associated administrative and financial burden.

Methods

A retrospective review was conducted of 833 new patients presenting to a single tertiary-care orthopedic spine practice over 6 months (April 2–October 31, 2024). Portal messages were categorized by timeframe and subject matter. Patients were classified as low- or high-volume (HV) users, with HV defined as ≥4 messages. Demographic predictors were assessed using independent t-tests and chi-square analyses. Messages meeting Centers for Medicare and Medicaid Services (CMS) criteria for billable Evaluation and Management (E/M) services were identified and assigned reimbursement values. A Monte Carlo simulation (100,000 iterations; R v4.5.1) estimated lost revenue from unbilled encounters.

Results

A total of 548 portal messages were sent (median 0 messages per patient; IQR 0–1). Common message topics included appointment scheduling (n=97), imaging-related concerns (n=94), postoperative issues (n=79), pain management (n=70), and third-party requests (n=59). High-volume utilization occurred in 43 patients (5.2%), with a mean of 5.19 messages per patient (range 3–18). Age was not associated with portal use (p=.276). Race was the only significant predictor of HV utilization (χ²=6.172, p=.046), with White/Caucasian patients overrepresented and Black/African American patients underrepresented. Only 25 messages (4.6%) met CMS billing criteria, primarily Level III E/M encounters (72%). Estimated median lost billable revenue was $7,501 (95% CI $3,845–$12,539).

Conclusions

Electronic patient portal (EPP) use in orthopedic spine surgery is highly skewed, with a small subset of patients generating disproportionate message volume. Despite limited billable encounters, portal messaging represents a growing administrative burden. Observed racial disparities highlight the need to further evaluate equity in digital patient engagement.
电子患者门户(EPPs)促进了患者和提供者之间的沟通,但其在骨科脊柱外科中的应用和影响尚不明确。本研究旨在量化门户消息的数量和内容,确定高利用率的人口统计预测因素,并估计相关的管理和财务负担。方法回顾性分析在2024年4月2日至10月31日6个月内就诊于同一家三级骨科诊所的833例新患者。门户消息按时间范围和主题进行分类。患者被分为低容量或高容量(HV)使用者,HV定义为≥4个消息。采用独立t检验和卡方分析评估人口统计学预测因子。确定了医疗保险和医疗补助服务(CMS)计费评估和管理(E/M)服务标准的消息会议中心,并分配了报销值。蒙特卡罗模拟(100,000次迭代;R v4.5.1)估计了未计费遭遇造成的收入损失。结果共发送门户信息548条(中位数0条/例,IQR 0 - 1条)。常见的信息主题包括预约安排(n=97)、成像相关问题(n=94)、术后问题(n=79)、疼痛管理(n=70)和第三方请求(n=59)。43例患者(5.2%)出现了高容量使用,平均每位患者5.19条信息(范围3-18)。年龄与门静脉使用无关(p= 0.276)。种族是唯一显著的HV利用预测因子(χ²=6.172,p= 0.046),白人/高加索患者比例过高,黑人/非裔美国患者比例过低。只有25条信息(4.6%)符合CMS计费标准,主要是三级E/M遭遇(72%)。估计损失的可计费收入中值为7501美元(95%可信区间为3845 - 12539美元)。结论电子患者门静脉(EPP)在骨科脊柱手术中的应用存在严重偏差,少数患者产生的信息量不成比例。尽管可计费的遭遇有限,但门户消息传递代表着日益增加的管理负担。观察到的种族差异突出了进一步评估数字患者参与公平性的必要性。
{"title":"Portal message utilization in orthopedic spine surgery: patterns, predictors, and financial implications","authors":"Sydney Rucker BA ,&nbsp;Michal C Williams BS ,&nbsp;Robert J. Ferdon MS ,&nbsp;Jason Silvestre MD ,&nbsp;Charles Reitman MD ,&nbsp;Robert Ravinsky MDCM, MPH, FRCSC","doi":"10.1016/j.xnsj.2025.100845","DOIUrl":"10.1016/j.xnsj.2025.100845","url":null,"abstract":"<div><h3>Background</h3><div>Electronic patient portals (EPPs) facilitate communication between patients and providers, but their utilization and impact in orthopedic spine surgery are poorly defined. This study aims to quantify portal message volume and content, identified demographic predictors of high utilization, and estimated the associated administrative and financial burden.</div></div><div><h3>Methods</h3><div>A retrospective review was conducted of 833 new patients presenting to a single tertiary-care orthopedic spine practice over 6 months (April 2–October 31, 2024). Portal messages were categorized by timeframe and subject matter. Patients were classified as low- or high-volume (HV) users, with HV defined as ≥4 messages. Demographic predictors were assessed using independent t-tests and chi-square analyses. Messages meeting Centers for Medicare and Medicaid Services (CMS) criteria for billable Evaluation and Management (E/M) services were identified and assigned reimbursement values. A Monte Carlo simulation (100,000 iterations; R v4.5.1) estimated lost revenue from unbilled encounters.</div></div><div><h3>Results</h3><div>A total of 548 portal messages were sent (median 0 messages per patient; IQR 0–1). Common message topics included appointment scheduling (<em>n</em>=97), imaging-related concerns (<em>n</em>=94), postoperative issues (<em>n</em>=79), pain management (<em>n</em>=70), and third-party requests (<em>n</em>=59). High-volume utilization occurred in 43 patients (5.2%), with a mean of 5.19 messages per patient (range 3–18). Age was not associated with portal use (p=.276). Race was the only significant predictor of HV utilization (χ²=6.172, p=.046), with White/Caucasian patients overrepresented and Black/African American patients underrepresented. Only 25 messages (4.6%) met CMS billing criteria, primarily Level III E/M encounters (72%). Estimated median lost billable revenue was $7,501 (95% CI $3,845–$12,539).</div></div><div><h3>Conclusions</h3><div>Electronic patient portal (EPP) use in orthopedic spine surgery is highly skewed, with a small subset of patients generating disproportionate message volume. Despite limited billable encounters, portal messaging represents a growing administrative burden. Observed racial disparities highlight the need to further evaluate equity in digital patient engagement.</div></div>","PeriodicalId":34622,"journal":{"name":"North American Spine Society Journal","volume":"25 ","pages":"Article 100845"},"PeriodicalIF":2.5,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel carbon fiber pedicle screw system for the treatment of lumbar degenerative disc disease: Results from a prospective, multicenter, FDA investigational device exemption study 新型碳纤维椎弓根螺钉系统用于治疗腰椎退行性椎间盘疾病:一项前瞻性、多中心、FDA研究器械豁免研究的结果
IF 2.5 Q3 Medicine Pub Date : 2025-12-23 DOI: 10.1016/j.xnsj.2025.100844
Scot Dean Miller DO, MBA , Rajiv V. Taliwal MD , Kathleen Opsitnick MSN, APRN, ACNP-BC , Brandy Mansfield MSN, APRN, ANP-BC , Thomas Cha MD , Mohamad Bydon MD , Anders Jonathan Cohen MD , Reuven Gepstein MD , Itzhak Engel MD , Joshef Leitner MD , Ely Ashkenazi MD , Michael Millgram MD , Yoram Folman MD , Carl Lauryssen MD

Background

Standard titanium pedicle screw systems are widely used in spinal fusion but produce imaging artifacts and may have limitations in fatigue resistance. CarboClear carbon fiber-reinforced PEEK (CFR-PEEK) implants offer improved radiolucency and fatigue properties, and negligible artifacts in MRI and CT scans. The purpose of this study was to evaluate the safety and effectiveness of CarboClear CFR-PEEK pedicle screw system for patients with degenerative disc disease (DDD) undergoing 1 level lumbar spinal fusion.

Methods

A prospective, multicenter, FDA-regulated Investigational Device Exemption (IDE) clinical trial, including 55 patients with DDD at 1 level (L2 to S1). Patients received the CarboClear System and a PEEK interbody fusion device. They were evaluated preoperatively and postoperatively at 6 weeks, 3, 6, 12, and 24 months, and then annually until the last patient completed 24-month follow-up. Primary outcome measures included self-reporting Visual Analog Scale (VAS) pain scores and Oswestry Disability Index (ODI), radiographic fusion rate, and safety assessments. Secondary measures included self-reporting SF-12 Health Survey (SF-12) scores and patient satisfaction (VAS), and operative parameters. Results were compared to predefined literature control group.

Results

At 24 months, 90.0% of the patients had clinically meaningful pain improvement (VAS ≥ 20), and 78.0% had ODI improvement ≥15 points. Rigorously defined fusion was achieved in 85.71% of the patients at 24 months and in 94.59% at 36 months. The neurological success rate was 93.33%. No serious device-related adverse events occurred. The 24-month index-level reoperation rate was 7.14%, including 1 implant removal case (1.79%). Compared to the literature control, CarboClear device demonstrated superior imaging clarity and at least equivalent clinical outcomes.

Conclusions

The CarboClear System is a safe and effective alternative to titanium pedicle screws for lumbar fusion, providing improved imaging compatibility and fatigue resistance.
标准钛椎弓根螺钉系统广泛用于脊柱融合术,但会产生成像伪影,并且在抗疲劳方面可能存在局限性。CarboClear碳纤维增强PEEK (CFR-PEEK)植入物具有更好的放射透光性和疲劳性能,并且在MRI和CT扫描中可以忽略伪影。本研究的目的是评估CarboClear CFR-PEEK椎弓根螺钉系统用于行1节段腰椎融合术的退行性椎间盘病患者的安全性和有效性。方法一项前瞻性,多中心,fda监管的研究性器械豁免(IDE)临床试验,包括55例1级(L2至S1) DDD患者。患者接受了CarboClear系统和PEEK体间融合装置。术前和术后分别于6周、3、6、12和24个月进行评估,然后每年评估一次,直到最后一位患者完成24个月的随访。主要结果测量包括自我报告视觉模拟量表(VAS)疼痛评分和Oswestry残疾指数(ODI)、放射融合率和安全性评估。次要措施包括自我报告SF-12健康调查(SF-12)评分和患者满意度(VAS),以及手术参数。结果与预设文献对照组进行比较。结果24个月时,90.0%的患者有临床意义的疼痛改善(VAS≥20),78.0%的患者ODI改善≥15分。严格定义的融合在24个月时达到85.71%,在36个月时达到94.59%。神经成功率为93.33%。未发生与器械相关的严重不良事件。24个月指数水平再手术率为7.14%,其中种植体拔除1例(1.79%)。与文献对照相比,CarboClear装置显示出更好的成像清晰度和至少相同的临床结果。结论CarboClear系统是一种安全有效的替代钛椎弓根螺钉进行腰椎融合的方法,具有更好的成像兼容性和抗疲劳性。
{"title":"Novel carbon fiber pedicle screw system for the treatment of lumbar degenerative disc disease: Results from a prospective, multicenter, FDA investigational device exemption study","authors":"Scot Dean Miller DO, MBA ,&nbsp;Rajiv V. Taliwal MD ,&nbsp;Kathleen Opsitnick MSN, APRN, ACNP-BC ,&nbsp;Brandy Mansfield MSN, APRN, ANP-BC ,&nbsp;Thomas Cha MD ,&nbsp;Mohamad Bydon MD ,&nbsp;Anders Jonathan Cohen MD ,&nbsp;Reuven Gepstein MD ,&nbsp;Itzhak Engel MD ,&nbsp;Joshef Leitner MD ,&nbsp;Ely Ashkenazi MD ,&nbsp;Michael Millgram MD ,&nbsp;Yoram Folman MD ,&nbsp;Carl Lauryssen MD","doi":"10.1016/j.xnsj.2025.100844","DOIUrl":"10.1016/j.xnsj.2025.100844","url":null,"abstract":"<div><h3>Background</h3><div>Standard titanium pedicle screw systems are widely used in spinal fusion but produce imaging artifacts and may have limitations in fatigue resistance. CarboClear carbon fiber-reinforced PEEK (CFR-PEEK) implants offer improved radiolucency and fatigue properties, and negligible artifacts in MRI and CT scans. The purpose of this study was to evaluate the safety and effectiveness of CarboClear CFR-PEEK pedicle screw system for patients with degenerative disc disease (DDD) undergoing 1 level lumbar spinal fusion.</div></div><div><h3>Methods</h3><div>A prospective, multicenter, FDA-regulated Investigational Device Exemption (IDE) clinical trial, including 55 patients with DDD at 1 level (L2 to S1). Patients received the CarboClear System and a PEEK interbody fusion device. They were evaluated preoperatively and postoperatively at 6 weeks, 3, 6, 12, and 24 months, and then annually until the last patient completed 24-month follow-up. Primary outcome measures included self-reporting Visual Analog Scale (VAS) pain scores and Oswestry Disability Index (ODI), radiographic fusion rate, and safety assessments. Secondary measures included self-reporting SF-12 Health Survey (SF-12) scores and patient satisfaction (VAS), and operative parameters. Results were compared to predefined literature control group.</div></div><div><h3>Results</h3><div>At 24 months, 90.0% of the patients had clinically meaningful pain improvement (VAS ≥ 20), and 78.0% had ODI improvement ≥15 points. Rigorously defined fusion was achieved in 85.71% of the patients at 24 months and in 94.59% at 36 months. The neurological success rate was 93.33%. No serious device-related adverse events occurred. The 24-month index-level reoperation rate was 7.14%, including 1 implant removal case (1.79%). Compared to the literature control, CarboClear device demonstrated superior imaging clarity and at least equivalent clinical outcomes.</div></div><div><h3>Conclusions</h3><div>The CarboClear System is a safe and effective alternative to titanium pedicle screws for lumbar fusion, providing improved imaging compatibility and fatigue resistance.</div></div>","PeriodicalId":34622,"journal":{"name":"North American Spine Society Journal","volume":"25 ","pages":"Article 100844"},"PeriodicalIF":2.5,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146037744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjacent segment degeneration after superior facet joint violation of the lumbar spine 腰椎上突关节侵犯后临近节段退变
IF 2.5 Q3 Medicine Pub Date : 2025-12-22 DOI: 10.1016/j.xnsj.2025.100843
Conor McNamee MB, BCh, BAO, MCh , Bryan Magee BSc , Richard N. Storey MBChB, FRACS , Jake M. McDonnell MRCS , Stacey Darwish MBChB, FRCS , Joseph S. Butler PhD, FRCS

Background

Facet joint violation (FJV) is a recognized complication of pedicle screw fixation and has been proposed as a driver of adjacent segment disease (ASD). Biomechanical models suggest that FJV may alter segmental kinematics, but its clinical impact on degeneration and reoperation remains uncertain. This work evaluates whether superior FJV is associated with an increased risk of radiographic ASD or reoperation after lumbar fusion.

Methods

Retrospective cohort study of patients undergoing lumbar pedicle screw fixation with postoperative CT imaging that captured the instrumentation and the cranial adjacent segment. Superior FJV was graded using an established 3-tier system. Follow-up imaging was assessed for disc height loss, progression of spondylolisthesis, coronal deformity, central stenosis, lateral recess height and a composite degeneration endpoint; reoperations were recorded. Propensity score weighting balanced measured covariates, and a weighted cox regression was used for time-to-event analyses.

Results

Seventy-one patients met inclusion criteria, with FJV identified in 35 (49.3%). Weighted analyses demonstrated no significant association between FJV and disc height loss (HR 1.21, 95% CI 0.54–2.72), progression of spondylolisthesis (HR 0.59, 95% CI 0.13–2.65), coronal deformity (HR 2.18, 95% CI 0.48–10.01), central stenosis (HR 1.35, 95% CI 0.21–8.61), composite degeneration (HR 1.76, 95% CI 0.87–3.56), or reoperation (HR 0.44, 95% CI 0.12–1.62). Exploratory subgroup analysis suggested that minor (grade 1) violations may contribute to axial instability, whereas full joint traversal (grade 2) may confer relative stability, though neither reached statistical significance.

Conclusions

In this cohort with extended follow-up, superior FJV was not significantly associated with any measure of radiographic degeneration or reoperation. These findings suggest that FJV may not be a major determinant of long-term outcomes after lumbar fusion. Further biomechanical and clinical studies are warranted to clarify whether specific grades of FJV differentially affect cranial segment stability and screw performance.

140 characters

Superior FJV on CT didn’t significantly increase hazards of disc height loss, listhesis, stenosis, deformity, or reop after fusion.
小关节侵犯(facet joint violation, FJV)是公认的椎弓根螺钉固定并发症,并被认为是邻近节段疾病(邻段疾病)的驱动因素。生物力学模型表明FJV可能改变节段运动学,但其对退变和再手术的临床影响尚不确定。本研究评估了FJV是否与影像学上ASD或腰椎融合术后再手术的风险增加有关。方法回顾性队列研究腰椎椎弓根螺钉固定患者的术后CT图像,记录内固定和颅邻近节段。采用已建立的三层体系对优质FJV进行分级。随访影像学评估椎间盘高度损失、椎体滑脱进展、冠状畸形、中央狭窄、外侧隐窝高度和复合退变终点;记录再手术。倾向得分加权平衡测量的协变量,加权cox回归用于时间-事件分析。结果71例患者符合纳入标准,其中35例(49.3%)为FJV。加权分析显示FJV与椎间盘高度损失(HR 1.21, 95% CI 0.54-2.72)、椎体滑脱进展(HR 0.59, 95% CI 0.13-2.65)、冠状畸形(HR 2.18, 95% CI 0.48-10.01)、中枢性狭窄(HR 1.35, 95% CI 0.21-8.61)、复合退变(HR 1.76, 95% CI 0.87-3.56)或再手术(HR 0.44, 95% CI 0.12-1.62)之间无显著相关性。探索性亚组分析表明,轻微(1级)骨折破坏可能导致轴向不稳定,而完全关节穿越(2级)可能导致相对稳定,但两者均未达到统计学意义。结论:在这个长期随访的队列中,优秀的FJV与任何影像学退行性变或再手术均无显著相关性。这些发现表明,FJV可能不是腰椎融合术后长期预后的主要决定因素。需要进一步的生物力学和临床研究来阐明FJV的不同级别是否会对颅段稳定性和螺钉性能产生不同的影响。CT上的高强度FJV并没有显著增加融合后椎间盘高度丢失、滑脱、狭窄、畸形或复位的危险。
{"title":"Adjacent segment degeneration after superior facet joint violation of the lumbar spine","authors":"Conor McNamee MB, BCh, BAO, MCh ,&nbsp;Bryan Magee BSc ,&nbsp;Richard N. Storey MBChB, FRACS ,&nbsp;Jake M. McDonnell MRCS ,&nbsp;Stacey Darwish MBChB, FRCS ,&nbsp;Joseph S. Butler PhD, FRCS","doi":"10.1016/j.xnsj.2025.100843","DOIUrl":"10.1016/j.xnsj.2025.100843","url":null,"abstract":"<div><h3>Background</h3><div>Facet joint violation (FJV) is a recognized complication of pedicle screw fixation and has been proposed as a driver of adjacent segment disease (ASD). Biomechanical models suggest that FJV may alter segmental kinematics, but its clinical impact on degeneration and reoperation remains uncertain. This work evaluates whether superior FJV is associated with an increased risk of radiographic ASD or reoperation after lumbar fusion.</div></div><div><h3>Methods</h3><div>Retrospective cohort study of patients undergoing lumbar pedicle screw fixation with postoperative CT imaging that captured the instrumentation and the cranial adjacent segment. Superior FJV was graded using an established 3-tier system. Follow-up imaging was assessed for disc height loss, progression of spondylolisthesis, coronal deformity, central stenosis, lateral recess height and a composite degeneration endpoint; reoperations were recorded. Propensity score weighting balanced measured covariates, and a weighted cox regression was used for time-to-event analyses.</div></div><div><h3>Results</h3><div>Seventy-one patients met inclusion criteria, with FJV identified in 35 (49.3%). Weighted analyses demonstrated no significant association between FJV and disc height loss (HR 1.21, 95% CI 0.54–2.72), progression of spondylolisthesis (HR 0.59, 95% CI 0.13–2.65), coronal deformity (HR 2.18, 95% CI 0.48–10.01), central stenosis (HR 1.35, 95% CI 0.21–8.61), composite degeneration (HR 1.76, 95% CI 0.87–3.56), or reoperation (HR 0.44, 95% CI 0.12–1.62). Exploratory subgroup analysis suggested that minor (grade 1) violations may contribute to axial instability, whereas full joint traversal (grade 2) may confer relative stability, though neither reached statistical significance.</div></div><div><h3>Conclusions</h3><div>In this cohort with extended follow-up, superior FJV was not significantly associated with any measure of radiographic degeneration or reoperation. These findings suggest that FJV may not be a major determinant of long-term outcomes after lumbar fusion. Further biomechanical and clinical studies are warranted to clarify whether specific grades of FJV differentially affect cranial segment stability and screw performance.</div></div><div><h3>140 characters</h3><div>Superior FJV on CT didn’t significantly increase hazards of disc height loss, listhesis, stenosis, deformity, or reop after fusion.</div></div>","PeriodicalId":34622,"journal":{"name":"North American Spine Society Journal","volume":"25 ","pages":"Article 100843"},"PeriodicalIF":2.5,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146037745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PMMA-augmentation of the spinous process as an enhancing-protective measure against bone failure in “through the spinous process-vertebropexy” pmma增强棘突作为“棘突椎体固定术”中防止骨衰竭的增强保护措施
IF 2.5 Q3 Medicine Pub Date : 2025-12-20 DOI: 10.1016/j.xnsj.2025.100842
Alexandros Tsolakidis MD , Marie-Rosa Fasser PhD , Oliver Wigger , Mazda Farshad MD , Jonas Widmer PhD

Background

Vertebropexy, a semi-rigid spinal stabilization technique, utilizes the spinous process(SP) as an anchor point for stabilizing tendon-grafts or flexible cerclages. In its primary form, it entailed drilling into the bone of 2 adjacent SPs and threading the materials through the holes. Biomechanical studies have identified the SP as the weakest part of the vertebrae, while cadaveric studies have demonstrated a higher bone failure rate with osteoporosis. We investigated whether cement augmentation of the SP could enhance the biomechanical strength and reduce the fracture-risk in the setting of first-generation Vertebropexy.

Methods

Following computed tomographic analysis and measurement of the bone mineral density, 12 lumbar segments were divided in 2 groups (Osteoporotic/ Nonosteoporotic) and then fixed in custom-made 3D-printed clamps. The SPs of 6 segments underwent cement augmentation (PMMA-Group), and a CT scan confirmed adequate augmentation. The other 6 segments remained uncemented. (Native-Group). Posterior decompression, drilling, and instrumentation with bovine tendons were then conducted. Torque-to-failure stress tests were performed on a biaxial static testing machine.

Results

The cement-augmentation of the SP significantly increases the torque-to-failure in flexion (p=.00037/ Median & IQR: 13.0 & 5.2 Nm in the Native-Group vs. 26.5 & 11.1 Nm in the PMMA-Group), regardless of the bone quality (p=.008). A statistically significant difference in torque-to-failure between Osteoporotic and NonOsteoporotic groups inside the PMMA and Native groups was determined (p=.015 and p=.025, respectively). A statistically significant correlation between bone density and failure torque was not detected in this cohort, possibly due to the limited sample size (Spearman 0.276, p=.192). A comparison between the torque-to-failure of the Native-NonOsteoporotic SPs and that of the PMMA-Osteoporotic showed no statistical significance (p=.240).

Conclusions

Based on the findings of this small-sample cadaveric study, cement-augmentation of the spinous processes can multiply the torque-to-failure/fracture in both osteoporotic and nonosteoporotic conditions and may be used as a salvage technique in first-generation vertebropexy procedures that compromise the spinous process.
背景椎体固定术是一种半刚性脊柱稳定技术,利用棘突(SP)作为稳定肌腱移植物或柔性环的锚点。在其最初的形式中,它需要在两个相邻的sp的骨头上钻孔,并将材料穿过这些孔。生物力学研究已经确定SP是椎骨最薄弱的部分,而尸体研究表明骨质疏松症的骨质衰竭率更高。我们研究了在第一代椎体固定术中,骨水泥增强SP是否能提高生物力学强度并降低骨折风险。方法将12节段腰椎分为骨质疏松组和非骨质疏松组,经计算机断层扫描分析和骨密度测量后,采用特制的3d打印夹固定。6节段SPs行骨水泥增强术(PMMA-Group), CT扫描证实增强足够。其余6个节段仍未胶结。(原来的群体)。然后用牛肌腱进行后路减压、钻孔和内固定。在双轴静态试验机上进行了扭矩-失效应力试验。结果无论骨质量如何(p= 0.008),骨水泥增强SP显著增加屈曲的扭矩(p= 0.00037 /中位IQR: native组13.0 & 5.2 Nm, pmma组26.5 & 11.1 Nm)。PMMA内骨质疏松组和非骨质疏松组和Native组的扭矩到失效的差异有统计学意义(p= 0.015和p= 0.025)。在这个队列中没有发现骨密度和失效扭矩之间有统计学意义的相关性,可能是由于样本量有限(Spearman 0.276, p= 0.192)。原生非骨质疏松性sp与pmma -骨质疏松性sp的转矩至衰竭的比较无统计学意义(p= 0.240)。基于这一小样本尸体研究的结果,骨水泥增强棘突可以增加骨质疏松和非骨质疏松情况下的扭矩至失效/骨折,并且可以作为损害棘突的第一代椎体固定术的挽救技术。
{"title":"PMMA-augmentation of the spinous process as an enhancing-protective measure against bone failure in “through the spinous process-vertebropexy”","authors":"Alexandros Tsolakidis MD ,&nbsp;Marie-Rosa Fasser PhD ,&nbsp;Oliver Wigger ,&nbsp;Mazda Farshad MD ,&nbsp;Jonas Widmer PhD","doi":"10.1016/j.xnsj.2025.100842","DOIUrl":"10.1016/j.xnsj.2025.100842","url":null,"abstract":"<div><h3>Background</h3><div>Vertebropexy, a semi-rigid spinal stabilization technique, utilizes the spinous process(SP) as an anchor point for stabilizing tendon-grafts or flexible cerclages. In its primary form, it entailed drilling into the bone of 2 adjacent SPs and threading the materials through the holes. Biomechanical studies have identified the SP as the weakest part of the vertebrae, while cadaveric studies have demonstrated a higher bone failure rate with osteoporosis. We investigated whether cement augmentation of the SP could enhance the biomechanical strength and reduce the fracture-risk in the setting of first-generation Vertebropexy.</div></div><div><h3>Methods</h3><div>Following computed tomographic analysis and measurement of the bone mineral density, 12 lumbar segments were divided in 2 groups (Osteoporotic/ Nonosteoporotic) and then fixed in custom-made 3D-printed clamps. The SPs of 6 segments underwent cement augmentation (PMMA-Group), and a CT scan confirmed adequate augmentation. The other 6 segments remained uncemented. (Native-Group). Posterior decompression, drilling, and instrumentation with bovine tendons were then conducted. Torque-to-failure stress tests were performed on a biaxial static testing machine.</div></div><div><h3>Results</h3><div>The cement-augmentation of the SP significantly increases the torque-to-failure in flexion (p=.00037/ Median &amp; IQR: 13.0 &amp; 5.2 Nm in the Native-Group vs. 26.5 &amp; 11.1 Nm in the PMMA-Group), regardless of the bone quality (p=.008). A statistically significant difference in torque-to-failure between Osteoporotic and NonOsteoporotic groups inside the PMMA and Native groups was determined (p=.015 and p=.025, respectively). A statistically significant correlation between bone density and failure torque was not detected in this cohort, possibly due to the limited sample size (Spearman 0.276, p=.192). A comparison between the torque-to-failure of the Native-NonOsteoporotic SPs and that of the PMMA-Osteoporotic showed no statistical significance (p=.240).</div></div><div><h3>Conclusions</h3><div>Based on the findings of this small-sample cadaveric study, cement-augmentation of the spinous processes can multiply the torque-to-failure/fracture in both osteoporotic and nonosteoporotic conditions and may be used as a salvage technique in first-generation vertebropexy procedures that compromise the spinous process.</div></div>","PeriodicalId":34622,"journal":{"name":"North American Spine Society Journal","volume":"25 ","pages":"Article 100842"},"PeriodicalIF":2.5,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145977245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The diagnostic value of metagenomic next-generation sequencing versus traditional microbiological testing in native pyogenic spinal infections: A systematic review and meta-analysis 新一代宏基因组测序与传统微生物检测在原发性化脓性脊柱感染中的诊断价值:一项系统综述和荟萃分析
IF 2.5 Q3 Medicine Pub Date : 2025-12-20 DOI: 10.1016/j.xnsj.2025.100840
Othman Ibrahim BS , Rewa Aboushaala , Namrah Ahmed MS , Andrew Savoia BS , Sloane O. Ward BS , Shriya N. Patel BS , Gregory Lopez MD , Sarah E. Sansom DO, MS , Brett Williams MD , Kern Singh MD , Lena Al-Harthi PhD , Khaled Aboushaala MD, MS, PhD

Background

Native pyogenic spinal infections (PSIs), including spondylodiscitis and vertebral osteomyelitis, are challenging to diagnose due to low culture sensitivity and delayed results. Metagenomic next-generation sequencing (mNGS) has emerged as a promising diagnostic tool, but its comparative clinical utility remains uncertain. The purpose of this study is to systematically compare the diagnostic performance and clinical impact of mNGS versus conventional microbial culture in detecting pathogens responsible for native PSIs.

Methods

The current systematic review and meta-analysis was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive literature search was performed across 6 major databases. Eligible studies directly compared mNGS with standard culture for native PSIs and reported diagnostic performance metrics. Data were extracted and analyzed using a random-effects model to produce pooled estimates. Study quality was assessed using the Newcastle-Ottawa Scale. Primary outcomes included pooled sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Secondary outcomes assessed diagnostic yield, time to diagnosis, treatment modification, and false-positive or contamination events.

Results

A total of 1,227 patients from 12 studies were included, encompassing those with suspected or confirmed native PSIs. Pooled sensitivity and specificity of mNGS were 89.7% (95% CI: 85.6–93.1%) and 86.2% (95% CI: 80.5–91.0%), respectively. mNGS demonstrated a significantly higher diagnostic yield (69–90%) compared to culture (27.2–44.7%) and enabled faster diagnosis (range, 17.7–48 hours). mNGS informed antimicrobial selection in up to 70.3% of cases and detected a broader pathogen spectrum. The incidence of false positives was low (range, 1–5) but non-negligible, emphasizing the need for careful interpretation.

Conclusions

mNGS outperforms conventional culture in sensitivity, speed, and breadth of pathogen detection in native PSIs and supports more tailored antimicrobial therapy. However, careful interpretation is necessary due to potential false positives. These findings support the integration of mNGS into clinical workflows, particularly in complex or culture-negative infections.
原生化脓性脊柱感染(PSIs),包括脊椎椎间盘炎和椎体骨髓炎,由于培养敏感性低和结果延迟,诊断具有挑战性。新一代宏基因组测序(mNGS)已成为一种很有前途的诊断工具,但其比较临床应用仍不确定。本研究的目的是系统地比较mNGS与传统微生物培养在检测本地PSIs病原体方面的诊断性能和临床影响。方法当前的系统评价和荟萃分析按照系统评价和荟萃分析的首选报告项目(PRISMA)指南进行。在6个主要数据库中进行了全面的文献检索。符合条件的研究直接将mNGS与本地psi的标准培养进行了比较,并报告了诊断性能指标。数据提取和分析使用随机效应模型,以产生汇总估计。使用纽卡斯尔-渥太华量表评估研究质量。主要结局包括敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。次要结局评估了诊断率、诊断时间、治疗修改、假阳性或污染事件。结果12项研究共纳入1227例患者,包括疑似或确诊的原生PSIs患者。mNGS的敏感性和特异性分别为89.7% (95% CI: 85.6-93.1%)和86.2% (95% CI: 80.5-91.0%)。与培养(27.2-44.7%)相比,mNGS的诊断率(69-90%)显着提高,诊断速度更快(范围,17.7-48小时)。在高达70.3%的病例中,mNGS为抗菌药物选择提供了信息,并检测到更广泛的病原体谱。假阳性的发生率很低(范围,1-5),但不可忽略,强调需要仔细解释。结论ngs在敏感性、检测速度和广度上优于传统培养,支持更有针对性的抗菌治疗。然而,由于潜在的误报,仔细的解释是必要的。这些发现支持将mNGS整合到临床工作流程中,特别是在复杂或培养阴性感染中。
{"title":"The diagnostic value of metagenomic next-generation sequencing versus traditional microbiological testing in native pyogenic spinal infections: A systematic review and meta-analysis","authors":"Othman Ibrahim BS ,&nbsp;Rewa Aboushaala ,&nbsp;Namrah Ahmed MS ,&nbsp;Andrew Savoia BS ,&nbsp;Sloane O. Ward BS ,&nbsp;Shriya N. Patel BS ,&nbsp;Gregory Lopez MD ,&nbsp;Sarah E. Sansom DO, MS ,&nbsp;Brett Williams MD ,&nbsp;Kern Singh MD ,&nbsp;Lena Al-Harthi PhD ,&nbsp;Khaled Aboushaala MD, MS, PhD","doi":"10.1016/j.xnsj.2025.100840","DOIUrl":"10.1016/j.xnsj.2025.100840","url":null,"abstract":"<div><h3>Background</h3><div>Native pyogenic spinal infections (PSIs), including spondylodiscitis and vertebral osteomyelitis, are challenging to diagnose due to low culture sensitivity and delayed results. Metagenomic next-generation sequencing (mNGS) has emerged as a promising diagnostic tool, but its comparative clinical utility remains uncertain. The purpose of this study is to systematically compare the diagnostic performance and clinical impact of mNGS versus conventional microbial culture in detecting pathogens responsible for native PSIs.</div></div><div><h3>Methods</h3><div>The current systematic review and meta-analysis was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive literature search was performed across 6 major databases. Eligible studies directly compared mNGS with standard culture for native PSIs and reported diagnostic performance metrics. Data were extracted and analyzed using a random-effects model to produce pooled estimates. Study quality was assessed using the Newcastle-Ottawa Scale. Primary outcomes included pooled sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Secondary outcomes assessed diagnostic yield, time to diagnosis, treatment modification, and false-positive or contamination events.</div></div><div><h3>Results</h3><div>A total of 1,227 patients from 12 studies were included, encompassing those with suspected or confirmed native PSIs. Pooled sensitivity and specificity of mNGS were 89.7% (95% CI: 85.6–93.1%) and 86.2% (95% CI: 80.5–91.0%), respectively. mNGS demonstrated a significantly higher diagnostic yield (69–90%) compared to culture (27.2–44.7%) and enabled faster diagnosis (range, 17.7–48 hours). mNGS informed antimicrobial selection in up to 70.3% of cases and detected a broader pathogen spectrum. The incidence of false positives was low (range, 1–5) but non-negligible, emphasizing the need for careful interpretation.</div></div><div><h3>Conclusions</h3><div>mNGS outperforms conventional culture in sensitivity, speed, and breadth of pathogen detection in native PSIs and supports more tailored antimicrobial therapy. However, careful interpretation is necessary due to potential false positives. These findings support the integration of mNGS into clinical workflows, particularly in complex or culture-negative infections.</div></div>","PeriodicalId":34622,"journal":{"name":"North American Spine Society Journal","volume":"25 ","pages":"Article 100840"},"PeriodicalIF":2.5,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145977248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stem cell therapy for degenerative disc disease: A systematic review of preclinical evidence, clinical translation, and future directions 干细胞治疗退行性椎间盘疾病:临床前证据、临床转化和未来方向的系统回顾
IF 2.5 Q3 Medicine Pub Date : 2025-12-19 DOI: 10.1016/j.xnsj.2025.100841
Vinicius Ricieri Ferraz MD , Carlos R. Goulart MD , Maria Fernanda Ricieri Ferraz Franco de Souza MD , Marcelo Ochoa Coelho de Souza Furlan MD , Philippe Mercier MD, PhD , Tobias A. Mattei MD, FACS

Background

Degenerative disc disease (DDD) is a leading contributor to chronic low back pain and global disability. Existing therapies, from conservative management to spinal fusion, do not reverse the underlying molecular degeneration, leaving a critical treatment gap. Given its regenerative capabilities the advent of stem-cell therapy may constitute an ideal solution to fulfill such a therapeutic gap.

Methods

This PRISMA-compliant systematic review evaluates stem cell–based strategies for intervertebral disc regeneration by examining preclinical evidence, clinical translation, and future directions. Searches of PubMed, Scopus, Web of Science, and related databases (from January 2000–May 2025) identified studies reporting on pain (Visual Analogue Scale), function (Oswestry Disability Index), and structural outcomes (MRI).

Results

Preclinical models uniformly demonstrate meaningful regeneration, including restoration of disc height and extracellular matrix. Clinical evidence, however, is limited: thirteen low to moderate-quality trials show modest, albeit statistically significant, improvements in pain and disability, without compelling imaging proof of biological repair. Short to mid-term safety appears acceptable.

Conclusions

The use of stem-cell therapy for treatment of degenerative disc disease is constrained by the somewhat hostile and avascular microenvironment of the intervertebral disc. Existing trials exhibit significant methodological weaknesses which substantially impair their application to the daily clinical practice. Future progress will likely depend on incorporating biomaterial-assisted delivery systems, cell-free exosome approaches, biological scaffolds and gene-editing technologies aimed at engineering the disc niche rather than simply focusing on cell replacement.
背景退行性椎间盘疾病(DDD)是慢性腰痛和全身残疾的主要原因。现有的治疗方法,从保守治疗到脊柱融合,都不能逆转潜在的分子变性,留下了一个关键的治疗空白。鉴于其再生能力,干细胞疗法的出现可能是填补这一治疗空白的理想解决方案。方法:这项符合prisma标准的系统综述通过检查临床前证据、临床转化和未来方向来评估基于干细胞的椎间盘再生策略。检索PubMed、Scopus、Web of Science和相关数据库(2000年1月至2025年5月),确定了关于疼痛(视觉模拟量表)、功能(Oswestry残疾指数)和结构结果(MRI)的研究报告。结果临床前模型均显示有意义的再生,包括椎间盘高度和细胞外基质的恢复。然而,临床证据是有限的:13个低到中等质量的试验显示,尽管在统计上有显著意义,但疼痛和残疾的改善程度有限,没有令人信服的生物修复的影像学证据。短期到中期的安全似乎是可以接受的。结论利用干细胞治疗退行性椎间盘疾病受到椎间盘微环境的限制。现有的试验在方法学上存在明显的缺陷,严重影响了其在日常临床实践中的应用。未来的进展可能取决于结合生物材料辅助递送系统、无细胞外泌体方法、生物支架和基因编辑技术,旨在设计椎间盘生态位,而不仅仅是专注于细胞替代。
{"title":"Stem cell therapy for degenerative disc disease: A systematic review of preclinical evidence, clinical translation, and future directions","authors":"Vinicius Ricieri Ferraz MD ,&nbsp;Carlos R. Goulart MD ,&nbsp;Maria Fernanda Ricieri Ferraz Franco de Souza MD ,&nbsp;Marcelo Ochoa Coelho de Souza Furlan MD ,&nbsp;Philippe Mercier MD, PhD ,&nbsp;Tobias A. Mattei MD, FACS","doi":"10.1016/j.xnsj.2025.100841","DOIUrl":"10.1016/j.xnsj.2025.100841","url":null,"abstract":"<div><h3>Background</h3><div>Degenerative disc disease (DDD) is a leading contributor to chronic low back pain and global disability. Existing therapies, from conservative management to spinal fusion, do not reverse the underlying molecular degeneration, leaving a critical treatment gap. Given its regenerative capabilities the advent of stem-cell therapy may constitute an ideal solution to fulfill such a therapeutic gap.</div></div><div><h3>Methods</h3><div>This PRISMA-compliant systematic review evaluates stem cell–based strategies for intervertebral disc regeneration by examining preclinical evidence, clinical translation, and future directions. Searches of PubMed, Scopus, Web of Science, and related databases (from January 2000–May 2025) identified studies reporting on pain (Visual Analogue Scale), function (Oswestry Disability Index), and structural outcomes (MRI).</div></div><div><h3>Results</h3><div>Preclinical models uniformly demonstrate meaningful regeneration, including restoration of disc height and extracellular matrix. Clinical evidence, however, is limited: thirteen low to moderate-quality trials show modest, albeit statistically significant, improvements in pain and disability, without compelling imaging proof of biological repair. Short to mid-term safety appears acceptable.</div></div><div><h3>Conclusions</h3><div>The use of stem-cell therapy for treatment of degenerative disc disease is constrained by the somewhat hostile and avascular microenvironment of the intervertebral disc. Existing trials exhibit significant methodological weaknesses which substantially impair their application to the daily clinical practice. Future progress will likely depend on incorporating biomaterial-assisted delivery systems, cell-free exosome approaches, biological scaffolds and gene-editing technologies aimed at engineering the disc niche rather than simply focusing on cell replacement.</div></div>","PeriodicalId":34622,"journal":{"name":"North American Spine Society Journal","volume":"25 ","pages":"Article 100841"},"PeriodicalIF":2.5,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145977247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on “Undetected low bone mineral density in patients undergoing lumbar fusion surgery: Prevalence and risk factors” 《腰椎融合术患者未被发现的低骨密度:患病率和危险因素》评论
IF 2.5 Q3 Medicine Pub Date : 2025-12-18 DOI: 10.1016/j.xnsj.2025.100839
Melissa Baker MD , Zorica Buser PhD, MBA
{"title":"Commentary on “Undetected low bone mineral density in patients undergoing lumbar fusion surgery: Prevalence and risk factors”","authors":"Melissa Baker MD ,&nbsp;Zorica Buser PhD, MBA","doi":"10.1016/j.xnsj.2025.100839","DOIUrl":"10.1016/j.xnsj.2025.100839","url":null,"abstract":"","PeriodicalId":34622,"journal":{"name":"North American Spine Society Journal","volume":"25 ","pages":"Article 100839"},"PeriodicalIF":2.5,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145926567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative complications after anterior cervical discectomy and fusion in patients with versus without carotid artery stenosis 颈动脉狭窄患者与非颈动脉狭窄患者颈前椎间盘切除术融合术后并发症的比较
IF 2.5 Q3 Medicine Pub Date : 2025-12-17 DOI: 10.1016/j.xnsj.2025.100838
Katie M. Zehner BS , Julian Smith-Voudouris MS , Joshua G. Sanchez BA , Sahir S. Jabbouri MD , Yoji Ogura MD, PhD , Basar Atalay MD, PhD , Jonathan N. Grauer MD , Arya G. Varthi MD

Background

Carotid artery stenosis (CS) may elevate risk of stroke related to anterior cervical discectomy and fusion (ACDF) due to manipulation of the carotid artery and alteration in flow dynamics. Prior studies assessing this potential association are limited by small sample size and assessment of in-hospital stroke only.

Methods

A retrospective cohort study was conducted to compare 90-day adverse events following ACDF in patients with versus without CS. Adult patients (age >17 years) without a history of stroke who underwent isolated 1-3 level ACDF were identified in the 2010-2023 PearlDiver M170 database. Patients with CS were matched 1:4 to patients without CS based on age, sex, and Elixhauser comorbidity index (ECI). Adverse outcomes, emergency department (ED) visits, and readmissions in the 90 postoperative days were identified and compared between groups with univariable and multivariable analyses, the latter controlling for age, sex, and ECI. The timing of stroke following surgery was also plotted on a Kaplan-Meier survival curve and compared by log-rank test. A secondary analysis was conducted comparing CS patients with and without a history of revascularization procedure.

Results

Among patients in the database undergoing ACDF, 17,772 with and 423,401 without CS were identified. Following matching, final cohorts consisted of 16,888 CS patients and 67,355 matched controls. CS was associated with greater odds of cardiac events (OR=1.74, p<.001) and stroke (OR=1.49, p<.001), but not other assessed adverse outcomes. The incidence of stroke continued to diverge for the 2 groups out to 90-days postoperatively. Of the CS patients, 2.8% had prior carotid revascularization. These patients had no difference in odds of stroke when compared to patients who had not undergone revascularization (p=.522)

Conclusions

ACDF patients with CS were found to be at significantly elevated odds of cardiac events and stroke (adverse outcomes associated with atherosclerotic burden), but not other assessed adverse outcomes. Surveillance of related symptoms through the perioperative period is importantly considered.
背景:颈动脉狭窄(CS)可能由于颈动脉的操作和血流动力学的改变而增加与颈前路椎间盘切除术和融合(ACDF)相关的卒中风险。先前评估这种潜在关联的研究受到样本量小和仅评估住院卒中的限制。方法采用回顾性队列研究,比较CS患者与非CS患者ACDF后90天的不良事件。在2010-2023年PearlDiver M170数据库中发现了无卒中史的1-3级ACDF的成年患者(年龄>;17岁)。根据年龄、性别和Elixhauser合并症指数(ECI), CS患者与非CS患者1:4配对。通过单变量分析和多变量分析确定并比较两组患者术后90天内的不良结局、急诊就诊和再入院情况,多变量分析控制年龄、性别和ECI。手术后卒中时间也绘制在Kaplan-Meier生存曲线上,并通过log-rank检验进行比较。对有和没有血运重建术史的CS患者进行了二次分析。结果在数据库中接受ACDF的患者中,有17,772例患有CS, 423,401例未患有CS。匹配后,最终队列由16,888名CS患者和67,355名匹配的对照组组成。CS与心脏事件(OR=1.74, p < lt; 0.001)和中风(OR=1.49, p < lt; 0.001)的发生率较高相关,但与其他评估的不良结局无关。术后90天,两组脑卒中发生率继续存在差异。在CS患者中,2.8%有过颈动脉血运重建术。与未接受血运重建术的患者相比,这些患者发生卒中的几率没有差异(p=.522)。结论sacdf合并CS的患者发生心脏事件和卒中的几率显著升高(与动脉粥样硬化负担相关的不良结局),但没有其他评估的不良结局。围手术期相关症状的监测是非常重要的。
{"title":"Postoperative complications after anterior cervical discectomy and fusion in patients with versus without carotid artery stenosis","authors":"Katie M. Zehner BS ,&nbsp;Julian Smith-Voudouris MS ,&nbsp;Joshua G. Sanchez BA ,&nbsp;Sahir S. Jabbouri MD ,&nbsp;Yoji Ogura MD, PhD ,&nbsp;Basar Atalay MD, PhD ,&nbsp;Jonathan N. Grauer MD ,&nbsp;Arya G. Varthi MD","doi":"10.1016/j.xnsj.2025.100838","DOIUrl":"10.1016/j.xnsj.2025.100838","url":null,"abstract":"<div><h3>Background</h3><div>Carotid artery stenosis (CS) may elevate risk of stroke related to anterior cervical discectomy and fusion (ACDF) due to manipulation of the carotid artery and alteration in flow dynamics. Prior studies assessing this potential association are limited by small sample size and assessment of in-hospital stroke only.</div></div><div><h3>Methods</h3><div>A retrospective cohort study was conducted to compare 90-day adverse events following ACDF in patients with versus without CS. Adult patients (age &gt;17 years) without a history of stroke who underwent isolated 1-3 level ACDF were identified in the 2010-2023 PearlDiver M170 database. Patients with CS were matched 1:4 to patients without CS based on age, sex, and Elixhauser comorbidity index (ECI). Adverse outcomes, emergency department (ED) visits, and readmissions in the 90 postoperative days were identified and compared between groups with univariable and multivariable analyses, the latter controlling for age, sex, and ECI. The timing of stroke following surgery was also plotted on a Kaplan-Meier survival curve and compared by log-rank test. A secondary analysis was conducted comparing CS patients with and without a history of revascularization procedure.</div></div><div><h3>Results</h3><div>Among patients in the database undergoing ACDF, 17,772 with and 423,401 without CS were identified. Following matching, final cohorts consisted of 16,888 CS patients and 67,355 matched controls. CS was associated with greater odds of cardiac events (OR=1.74, p&lt;.001) and stroke (OR=1.49, p&lt;.001), but not other assessed adverse outcomes. The incidence of stroke continued to diverge for the 2 groups out to 90-days postoperatively. Of the CS patients, 2.8% had prior carotid revascularization. These patients had no difference in odds of stroke when compared to patients who had not undergone revascularization (p=.522)</div></div><div><h3>Conclusions</h3><div>ACDF patients with CS were found to be at significantly elevated odds of cardiac events and stroke (adverse outcomes associated with atherosclerotic burden), but not other assessed adverse outcomes. Surveillance of related symptoms through the perioperative period is importantly considered.</div></div>","PeriodicalId":34622,"journal":{"name":"North American Spine Society Journal","volume":"25 ","pages":"Article 100838"},"PeriodicalIF":2.5,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145926566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
North American Spine Society Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1